Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials

From MaRDI portal
Publication:91853

DOI10.1016/J.CCT.2010.07.008WikidataQ42141287 ScholiaQ42141287MaRDI QIDQ91853

A.P. Mander, S.G. Thompson

Publication date: November 2010

Published in: Contemporary Clinical Trials (Search for Journal in Brave)




Related Items (2)







This page was built for publication: Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials